Potential subversion of pregnancy prevention program in the managed care setting.
Wilkin
J K
JK
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D003267:Contraception; D004348:Drug Labeling; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects*; D008329:Managed Care Programs; D013723:Teratogens; D014481:United States; D014486:United States Food and Drug Administration
D013723:Teratogens; D015474:Isotretinoin